penicillanic acid has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Akashi, K; Harada, N; Iwasaki, H; Kamezaki, K; Miyamoto, T; Mori, Y; Nagasaki, Y; Shimono, N; Takenaka, K; Teshima, T | 1 |
| Cipriani, P; Nicoletti, M; Petrucca, A; Pustorino, R; Santapaola, D; Sessa, R; Teggi, A | 1 |
2 other study(ies) available for penicillanic acid and Multiple Myeloma
| Article | Year |
|---|---|
High incidence of false-positive Aspergillus galactomannan test in multiple myeloma.
Topics: Amoxicillin; Antibiotic Prophylaxis; Antigens, Fungal; Artifacts; Aspergillosis; Aspergillus; False Positive Reactions; Galactose; Hematologic Diseases; Hematologic Neoplasms; Humans; Immunoglobulin G; Mannans; Multiple Myeloma; Myeloma Proteins; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sensitivity and Specificity | 2010 |
Burkholderia cenocepacia vaginal infection in patient with smoldering myeloma and chronic hepatitis C.
Topics: Aged; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Drug Resistance, Multiple, Bacterial; Female; Hepatitis C, Chronic; Humans; Multiple Myeloma; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vaginosis, Bacterial | 2004 |